Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm CasesDermatology / Mycology / General Practice

Derm Cases · Dermatology / Mycology / General Practice

OSCE — hypopigmented truncal scale: pityriasis versicolor diagnosis and antifungal therapy

An 8-minute OSCE station on clinical diagnosis of pityriasis versicolor, KOH/Wood lamp concepts, differential of hypopigmented patches, topical and systemic antifungal choices, and counselling on pigment recovery and recurrence.

8 minosce1 min readVerification in progress

Target exams

NEET-PGINICETUSMLEPLABMRCP
On this page
Study tools

Target exams

NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on clinical diagnosis of pityriasis versicolor, KOH/Wood lamp concepts, differential of hypopigmented patches, topical and systemic antifungal choices, and counselling on pigment recovery and recurrence.

Brief (to candidate)

A 24-year-old man notices coalescing pale, finely scaly patches on the upper chest and back after summer gym training. The patches do not tan with the surrounding skin. Itch is mild. You have 8 minutes to diagnose, confirm, treat, and counsel on recurrence and pigment return.

Candidate instructions

  1. Recognise pityriasis versicolor (tinea versicolor) morphology and seborrhoeic distribution.
  2. List key differentials for hypopigmented patches.
  3. Use KOH / Wood lamp / dermoscopy concepts appropriately.
  4. Prescribe topical ± oral antifungal correctly.
  5. Counsel pigment lag and recurrence prevention.
[9]

Examiner checklist (mark each domain / 10)

DomainKey actions expected
RecognitionWell-demarcated hypo- or hyperpigmented macules with fine branny scale on seborrhoeic trunk/shoulders/neck; often young adults, heat/sweat/oil triggers[1][2]
OrganismMalassezia yeast (lipophilic skin flora) overgrowth — not a dermatophyte “ringworm” in the classic sense; explain why terbinafine oral is not first-line here[3]
InvestigationsOften clinical; KOH shows classic spaghetti-and-meatballs (hyphae + spores); Wood lamp may show yellow-green fluorescence (not always); dermoscopy fine scale in furrows when available[1][9]
DifferentialVitiligo (absolute chalk-white, no scale), pityriasis alba, progressive macular hypomelanosis, seborrhoeic dermatitis, early tinea corporis, post-inflammatory hypopigmentation
TreatmentTopical ketoconazole/selenium sulfide/azole shampoos or creams as first-line; oral itraconazole or fluconazole for extensive/recalcitrant disease per local protocol — not routine oral terbinafine for PV[10][11]
CounsellingColour takes weeks–months to normalise after yeast cleared — not treatment failure; recurrence common in hot climates — periodic preventive shampoo
CommunicationReassure non-contagious in usual social sense (endogenous flora); return if no improvement or diagnostic doubt

Model key actions

  • Diagnose PV from truncal branny hypo/hyperpigmented scale in a young adult.[1]
  • Confirm with KOH spaghetti-and-meatballs when needed; treat with topical azole/selenium ± oral azole if extensive.[3][10]
  • Counsel that pigment recovery lags mycological cure and recurrence is common.[11]

Common errors

  • Calling it vitiligo and starting unnecessary anxiety/work-up without noting scale.
  • Using oral terbinafine as if dermatophyte tinea corporis.
  • Declaring failure at 1 week because colour has not returned.
[3]
  • Missing extensive disease that needs systemic therapy or confirmation.
  • No recurrence prevention plan in sweaty tropical settings.
References6ShowHide
  1. [1]Łabędź N, Navarrete-Dechent C, Kubisiak-Rzepczyk H, Bowszyc-Dmochowska M, Pogorzelska-Antkowiak A, Pietkiewicz P. Pityriasis Versicolor-A Narrative Review on the Diagnosis and Management. Life (Basel), 2023.PMID 37895478
  2. [2]Gold JAW, Benedict K, Lipner SR. Pityriasis versicolor epidemiology, disease predictors, and health care utilization: Analysis of 32,679 cases in a large commercial insurance database. Journal of the American Academy of Dermatology, 2025.PMID 39389424
  3. [3]Crespo-Erchiga V, Florencio VD Malassezia yeasts and pityriasis versicolor. Current Opinion in Infectious Diseases, 2006.PMID 16514338
  4. [9]Thomas N, Malakar S. Dermoscopy: An easy way to solve the diagnostic puzzle in pityriasis versicolor. Indian Journal of Dermatology, Venereology and Leprology, 2019.PMID 30117461
  5. [10]Gupta AK, Foley KA. Antifungal Treatment for Pityriasis Versicolor. Journal of Fungi (Basel), 2015.PMID 29376896
  6. [11]Hu SW, Bigby M. Pityriasis versicolor: a systematic review of interventions. Archives of Dermatology, 2010.PMID 20956647
PreviousOSCE — Hypohidrotic ectodermal dysplasia: triad, heat risk, geneticsDermatology / Paediatrics / Genetics / DentistryNextOSCE — indurated trunk plaque: DFSP diagnosis, Mohs preference and imatinib pathwayDermatology / Soft-tissue sarcoma